Global Androgenic Alopecia Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 935158 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Medicine
        1.2.3 Surgery
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Androgenic Alopecia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Androgenic Alopecia Therapeutics Market Perspective (2016-2027)
    2.2 Androgenic Alopecia Therapeutics Growth Trends by Regions
        2.2.1 Androgenic Alopecia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Androgenic Alopecia Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Androgenic Alopecia Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Androgenic Alopecia Therapeutics Industry Dynamic
        2.3.1 Androgenic Alopecia Therapeutics Market Trends
        2.3.2 Androgenic Alopecia Therapeutics Market Drivers
        2.3.3 Androgenic Alopecia Therapeutics Market Challenges
        2.3.4 Androgenic Alopecia Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue
        3.1.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Androgenic Alopecia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Androgenic Alopecia Therapeutics Revenue
    3.4 Global Androgenic Alopecia Therapeutics Market Concentration Ratio
        3.4.1 Global Androgenic Alopecia Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Androgenic Alopecia Therapeutics Revenue in 2020
    3.5 Androgenic Alopecia Therapeutics Key Players Head office and Area Served
    3.6 Key Players Androgenic Alopecia Therapeutics Product Solution and Service
    3.7 Date of Enter into Androgenic Alopecia Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Androgenic Alopecia Therapeutics Breakdown Data by Type
    4.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Androgenic Alopecia Therapeutics Breakdown Data by Application
    5.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Androgenic Alopecia Therapeutics Market Size (2016-2027)
    6.2 North America Androgenic Alopecia Therapeutics Market Size by Type
        6.2.1 North America Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
    6.3 North America Androgenic Alopecia Therapeutics Market Size by Application
        6.3.1 North America Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
    6.4 North America Androgenic Alopecia Therapeutics Market Size by Country
        6.4.1 North America Androgenic Alopecia Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Androgenic Alopecia Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Androgenic Alopecia Therapeutics Market Size (2016-2027)
    7.2 Europe Androgenic Alopecia Therapeutics Market Size by Type
        7.2.1 Europe Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Androgenic Alopecia Therapeutics Market Size by Application
        7.3.1 Europe Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Androgenic Alopecia Therapeutics Market Size by Country
        7.4.1 Europe Androgenic Alopecia Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Androgenic Alopecia Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Androgenic Alopecia Therapeutics Market Size (2016-2027)
    9.2 Latin America Androgenic Alopecia Therapeutics Market Size by Type
        9.2.1 Latin America Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Androgenic Alopecia Therapeutics Market Size by Application
        9.3.1 Latin America Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Androgenic Alopecia Therapeutics Market Size by Country
        9.4.1 Latin America Androgenic Alopecia Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Androgenic Alopecia Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Company Details
        11.1.2 Johnson & Johnson Business Overview
        11.1.3 Johnson & Johnson Androgenic Alopecia Therapeutics Introduction
        11.1.4 Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.1.5 Johnson & Johnson Recent Development
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Merck Business Overview
        11.2.3 Merck Androgenic Alopecia Therapeutics Introduction
        11.2.4 Merck Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.2.5 Merck Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Introduction
        11.3.4 GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Astellas Pharma
        11.4.1 Astellas Pharma Company Details
        11.4.2 Astellas Pharma Business Overview
        11.4.3 Astellas Pharma Androgenic Alopecia Therapeutics Introduction
        11.4.4 Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.4.5 Astellas Pharma Recent Development
    11.5 Cipla
        11.5.1 Cipla Company Details
        11.5.2 Cipla Business Overview
        11.5.3 Cipla Androgenic Alopecia Therapeutics Introduction
        11.5.4 Cipla Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.5.5 Cipla Recent Development
    11.6 Almirall
        11.6.1 Almirall Company Details
        11.6.2 Almirall Business Overview
        11.6.3 Almirall Androgenic Alopecia Therapeutics Introduction
        11.6.4 Almirall Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.6.5 Almirall Recent Development
    11.7 Sun Pharma
        11.7.1 Sun Pharma Company Details
        11.7.2 Sun Pharma Business Overview
        11.7.3 Sun Pharma Androgenic Alopecia Therapeutics Introduction
        11.7.4 Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.7.5 Sun Pharma Recent Development
    11.8 Reddy's Laboratories
        11.8.1 Reddy's Laboratories Company Details
        11.8.2 Reddy's Laboratories Business Overview
        11.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Introduction
        11.8.4 Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.8.5 Reddy's Laboratories Recent Development
    11.9 Concert Pharmaceuticals
        11.9.1 Concert Pharmaceuticals Company Details
        11.9.2 Concert Pharmaceuticals Business Overview
        11.9.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Introduction
        11.9.4 Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.9.5 Concert Pharmaceuticals Recent Development
    11.10 RiverTown Therapeutics
        11.10.1 RiverTown Therapeutics Company Details
        11.10.2 RiverTown Therapeutics Business Overview
        11.10.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Introduction
        11.10.4 RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.10.5 RiverTown Therapeutics Recent Development
    11.11 Brickell Biotech
        11.11.1 Brickell Biotech Company Details
        11.11.2 Brickell Biotech Business Overview
        11.11.3 Brickell Biotech Androgenic Alopecia Therapeutics Introduction
        11.11.4 Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.11.5 Brickell Biotech Recent Development
    11.12 BiologicsMD
        11.12.1 BiologicsMD Company Details
        11.12.2 BiologicsMD Business Overview
        11.12.3 BiologicsMD Androgenic Alopecia Therapeutics Introduction
        11.12.4 BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.12.5 BiologicsMD Recent Development
    11.13 Aclaris Therapeutics
        11.13.1 Aclaris Therapeutics Company Details
        11.13.2 Aclaris Therapeutics Business Overview
        11.13.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Introduction
        11.13.4 Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
        11.13.5 Aclaris Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Medicine
    Table 3. Key Players of Surgery
    Table 4. Key Players of Other
    Table 5. Global Androgenic Alopecia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Androgenic Alopecia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Androgenic Alopecia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Androgenic Alopecia Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Androgenic Alopecia Therapeutics Market Share by Regions (2022-2027)
    Table 11. Androgenic Alopecia Therapeutics Market Trends
    Table 12. Androgenic Alopecia Therapeutics Market Drivers
    Table 13. Androgenic Alopecia Therapeutics Market Challenges
    Table 14. Androgenic Alopecia Therapeutics Market Restraints
    Table 15. Global Androgenic Alopecia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Androgenic Alopecia Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgenic Alopecia Therapeutics as of 2020)
    Table 18. Ranking of Global Top Androgenic Alopecia Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Androgenic Alopecia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Androgenic Alopecia Therapeutics Product Solution and Service
    Table 22. Date of Enter into Androgenic Alopecia Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Androgenic Alopecia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Androgenic Alopecia Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Androgenic Alopecia Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Androgenic Alopecia Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Androgenic Alopecia Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Androgenic Alopecia Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Androgenic Alopecia Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Johnson & Johnson Company Details
    Table 63. Johnson & Johnson Business Overview
    Table 64. Johnson & Johnson Androgenic Alopecia Therapeutics Product
    Table 65. Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Johnson & Johnson Recent Development
    Table 67. Merck Company Details
    Table 68. Merck Business Overview
    Table 69. Merck Androgenic Alopecia Therapeutics Product
    Table 70. Merck Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Merck Recent Development
    Table 72. GlaxoSmithKline Company Details
    Table 73. GlaxoSmithKline Business Overview
    Table 74. GlaxoSmithKline Androgenic Alopecia Therapeutics Product
    Table 75. GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. GlaxoSmithKline Recent Development
    Table 77. Astellas Pharma Company Details
    Table 78. Astellas Pharma Business Overview
    Table 79. Astellas Pharma Androgenic Alopecia Therapeutics Product
    Table 80. Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Astellas Pharma Recent Development
    Table 82. Cipla Company Details
    Table 83. Cipla Business Overview
    Table 84. Cipla Androgenic Alopecia Therapeutics Product
    Table 85. Cipla Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Cipla Recent Development
    Table 87. Almirall Company Details
    Table 88. Almirall Business Overview
    Table 89. Almirall Androgenic Alopecia Therapeutics Product
    Table 90. Almirall Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Almirall Recent Development
    Table 92. Sun Pharma Company Details
    Table 93. Sun Pharma Business Overview
    Table 94. Sun Pharma Androgenic Alopecia Therapeutics Product
    Table 95. Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Sun Pharma Recent Development
    Table 97. Reddy's Laboratories Company Details
    Table 98. Reddy's Laboratories Business Overview
    Table 99. Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Reddy's Laboratories Recent Development
    Table 101. Concert Pharmaceuticals Company Details
    Table 102. Concert Pharmaceuticals Business Overview
    Table 103. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product
    Table 104. Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Concert Pharmaceuticals Recent Development
    Table 106. RiverTown Therapeutics Company Details
    Table 107. RiverTown Therapeutics Business Overview
    Table 108. RiverTown Therapeutics Androgenic Alopecia Therapeutics Product
    Table 109. RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. RiverTown Therapeutics Recent Development
    Table 111. Brickell Biotech Company Details
    Table 112. Brickell Biotech Business Overview
    Table 113. Brickell Biotech Androgenic Alopecia Therapeutics Product
    Table 114. Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 115. Brickell Biotech Recent Development
    Table 116. BiologicsMD Company Details
    Table 117. BiologicsMD Business Overview
    Table 118. BiologicsMD Androgenic Alopecia Therapeutics Product
    Table 119. BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 120. BiologicsMD Recent Development
    Table 121. Aclaris Therapeutics Company Details
    Table 122. Aclaris Therapeutics Business Overview
    Table 123. Aclaris Therapeutics Androgenic Alopecia Therapeutics Product
    Table 124. Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
    Table 125. Aclaris Therapeutics Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Androgenic Alopecia Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Medicine Features
    Figure 3. Surgery Features
    Figure 4. Other Features
    Figure 5. Global Androgenic Alopecia Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Other Case Studies
    Figure 9. Androgenic Alopecia Therapeutics Report Years Considered
    Figure 10. Global Androgenic Alopecia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Androgenic Alopecia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Androgenic Alopecia Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 13. Global Androgenic Alopecia Therapeutics Market Share by Regions (2022-2027)
    Figure 14. Global Androgenic Alopecia Therapeutics Market Share by Players in 2020
    Figure 15. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgenic Alopecia Therapeutics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Androgenic Alopecia Therapeutics Revenue in 2020
    Figure 17. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 18. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 19. North America Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
    Figure 21. North America Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
    Figure 22. North America Androgenic Alopecia Therapeutics Market Share by Country (2016-2027)
    Figure 23. United States Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
    Figure 27. Europe Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
    Figure 28. Europe Androgenic Alopecia Therapeutics Market Share by Country (2016-2027)
    Figure 29. Germany Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Androgenic Alopecia Therapeutics Market Share by Region (2016-2027)
    Figure 39. China Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
    Figure 47. Latin America Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
    Figure 48. Latin America Androgenic Alopecia Therapeutics Market Share by Country (2016-2027)
    Figure 49. Mexico Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Country (2016-2027)
    Figure 55. Turkey Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 59. Merck Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 60. GlaxoSmithKline Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 61. Astellas Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 62. Cipla Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 63. Almirall Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 64. Sun Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 65. Reddy's Laboratories Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 66. Concert Pharmaceuticals Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 67. RiverTown Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 68. Brickell Biotech Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 69. BiologicsMD Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 70. Aclaris Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy's Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics
Frequently Asked Questions
Androgenic Alopecia Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Androgenic Alopecia Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Androgenic Alopecia Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aneurysm Therapeutics

An aneurysm is the enlargement of an artery caused by weakness in the arterial wall.
Read More

Aortic Aneurysm

An aortic aneurysm is an enlargement (dilatation) of the aortato greater than 1.5 times normal ... Read More